Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.03 -0.18 (-1.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Selling, General & Administrative (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) recorded Selling, General & Administrative of $10.99 million in Q2 2026, up 6.3% from $10.34 million a year earlier and up 16.1% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Selling, General & Administrative (2018 - 2026) Analysis & Trends

On a TTM basis, Arcturus Therapeutics Holdings' Selling, General & Administrative came in at $44.88 million as of Jun 30, 2026, down 5.1% year-over-year; for FY2025, it was $46.08 million, down 12.8% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 14.7% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $52.82 million in FY2024 (-0.1%), $52.87 million in FY2023 (+14.8%), $46.07 million in FY2022 (+11.1%) and $41.45 million in FY2021 (+78.5%).
  • Quarterly Selling, General & Administrative has ranged from $9.47 million in Q1 2026 to $14.85 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative rose in two of the last eight quarters, with an average decline of 7.5%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 94.9% in Q3 2021, against a decline of 23.8% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $9.47 million (Q1 2026), $14.03 million (Q4 2025) and $10.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 Arcturus Therapeutics Holdings 375.47 Mn -438.66 Mn - 10.99 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.99 Mn
Mar 31, 2026 9.47 Mn
Dec 31, 2025 14.03 Mn
Sep 30, 2025 10.40 Mn
Jun 30, 2025 10.34 Mn
Mar 31, 2025 11.32 Mn
Dec 31, 2024 12.38 Mn
Sep 30, 2024 13.28 Mn
Jun 30, 2024 12.32 Mn
Mar 31, 2024 14.85 Mn
Dec 31, 2023 12.51 Mn
Sep 30, 2023 13.38 Mn
Jun 30, 2023 13.23 Mn
Mar 31, 2023 13.76 Mn
Dec 31, 2022 11.86 Mn
Sep 30, 2022 12.49 Mn
Jun 30, 2022 10.99 Mn
Mar 31, 2022 10.73 Mn
Dec 31, 2021 10.81 Mn
Sep 30, 2021 10.86 Mn
API Access

Arcturus Therapeutics Holdings Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ARCT&period=max&api_key=YOUR_API_KEY